Inhibitory układy RAAS a COVID-19: edytorial w NEJM

John A. Jarcho i wsp.Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19. N Eng J Med online 2020 (dostępny pełen tekst)

Professional scientific societies and experts have spoken with one voice in advising that patients should not discontinue ACE inhibitor or ARB therapy out of a concern that they are at increased risk for infection, severe illness, or death during the Covid-19 pandemic. The data from these three studies support those recommendations. Ultimately, one or more randomized trials will be needed …

New England Journal of Medicine, 1 maja 2020

Dodaj komentarz